November 16, 2023
A Japanese health ministry panel on November 15 approved a 7.8% downward price adjustment for argenx’s Vyvgart (efgartigimod alfa) under the cost-effectiveness assessment (CEA) scheme. Two other drugs are in for price reductions as well, but by slim margins, with...read more